The modulatory role of high fat feeding on gastrointestinal signals in obesity

Journal of Nutritional Biochemistry

Volumn 24, Issue 10, 2013, Pages 1663-1677

  Duca, Frank A ^a,b   Sakar, Yassine ^a   Covasa, Mihai ^a,c,d  

^a UMR1319 MICALIS   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^d STEFAN CEL MARE UNIVERSITY OF SUCEAVA   (Romania)

Author keywords

Diet adaptation; GPR; Gut peptides; Microbiota; Satiation; Taste

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ OCTAPEPTIDE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; PEPTIDE YY;

CALORIC INTAKE; FAT INTAKE; GASTROINTESTINAL TRACT; HUMAN; INTESTINE FLORA; LIPID ABSORPTION; LONG TERM EXPOSURE; NONHUMAN; OBESITY; REGULATORY MECHANISM; REVIEW; SATIETY; SIGNAL TRANSDUCTION; WEIGHT GAIN;

DIET ADAPTATION; GPR; GUT PEPTIDES; MICROBIOTA; SATIATION; TASTE;

ADIPOSITY; ANIMALS; ANTIGENS, CD36; CHOLECYSTOKININ; DIETARY FATS; ENERGY INTAKE; GASTROINTESTINAL TRACT; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INTESTINAL ABSORPTION; MICROBIOTA; OBESITY; PEPTIDE YY; RECEPTORS, G-PROTEIN-COUPLED; SATIATION; SIGNAL TRANSDUCTION; TASTE; WEIGHT GAIN;

EID: 84883805292     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.05.005     Document Type: Review

References (270)

1. Wang Y.C., McPherson K., Marsh T., Gortmaker S.L., Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 2011, 378(9793):815-825.
2. Berthoud H.R. Brain, appetite and obesity. Physiol Behav 2005, 85(1):1-2.
3. Golay A., Bobbioni E. The role of dietary fat in obesity. Int J Obes Relat Metab Disord 1997, 21(Suppl 3):S2-S11.
4. Bray G.A., Paeratakul S., Popkin B.M. Dietary fat and obesity: a review of animal, clinical and epidemiological studies. Physiol Behav 2004, 83(4):549-555.
5. Mattes R.D. Is there a fatty acid taste?. Annu Rev Nutr 2009, 29:305-327.
6. Chale-Rush A., Burgess J.R., Mattes R.D. Evidence for human orosensory (taste?) sensitivity to free fatty acids. Chem Senses 2007, 32(5):423-431.
7. Chale-Rush A., Burgess J.R., Mattes R.D. Multiple routes of chemosensitivity to free fatty acids in humans. Am J Physiol Gastrointest Liver Physiol 2007, 292(5):G1206-G1212.
8. Gaillard D., Laugerette F., Darcel N., El-Yassimi A., Passilly-Degrace P., Hichami A., et al. The gustatory pathway is involved in CD36-mediated orosensory perception of long-chain fatty acids in the mouse. FASEB J 2008, 22(5):1458-1468.
9. McCormack D.N., Clyburn V.L., Pittman D.W. Detection of free fatty acids following a conditioned taste aversion in rats. Physiol Behav 2006, 87(3):582-594.
10. Tanaka T., Katsuma S., Adachi T., Koshimizu T.A., Hirasawa A., Tsujimoto G. Free fatty acids induce cholecystokinin secretion through GPR120. Naunyn Schmiedebergs Arch Pharmacol 2008, 377(4-6):523-527.
11. Tsuruta M., Kawada T., Fukuwatari T., Fushiki T. The orosensory recognition of long-chain fatty acids in rats. Physiol Behav 1999, 66(2):285-288.
12. Takeda M., Imaizumi M., Fushiki T. Preference for vegetable oils in the two-bottle choice test in mice. Life Sci 2000, 67(2):197-204.
13. Takeda M., Sawano S., Imaizumi M., Fushiki T. Preference for corn oil in olfactory-blocked mice in the conditioned place preference test and the two-bottle choice test. Life Sci 2001, 69(7):847-854.
14. Gilbertson T.A., Fontenot D.T., Liu L., Zhang H., Monroe W.T. Fatty acid modulation of K+ channels in taste receptor cells: gustatory cues for dietary fat. Am J Physiol 1997, 272(4 Pt 1):C1203-C1210.
15. Kawai T., Fushiki T. Importance of lipolysis in oral cavity for orosensory detection of fat. Am J Physiol Regul Integr Comp Physiol 2003, 285(2):R447-R454.
16. Stewart J.E., Feinle-Bisset C., Golding M., Delahunty C., Clifton P.M., Keast R.S. Oral sensitivity to fatty acids, food consumption and BMI in human subjects. Br J Nutr 2010, 104(1):145-152.
17. Kulkarni B., Mattes R. Evidence for presence of nonesterified fatty acids as potential gustatory signaling molecules in humans. Chem Senses 2012, 38(2):119-127.
18. Fukuwatari T., Kawada T., Tsuruta M., Hiraoka T., Iwanaga T., Sugimoto E., et al. Expression of the putative membrane fatty acid transporter (FAT) in taste buds of the circumvallate papillae in rats. FEBS Lett 1997, 414(2):461-464.
19. Laugerette F., Passilly-Degrace P., Patris B., Niot I., Febbraio M., Montmayeur J.P., et al. CD36 involvement in orosensory detection of dietary lipids, spontaneous fat preference, and digestive secretions. J Clin Invest 2005, 115(11):3177-3184.
20. Matsumura S., Mizushige T., Yoneda T., Iwanaga T., Tsuzuki S., Inoue K., et al. GPR expression in the rat taste bud relating to fatty acid sensing. Biomed Res 2007, 28(1):49-55.
21. Galindo M.M., Voigt N., Stein J., van Lengerich J., Raguse J.D., Hofmann T., et al. G protein-coupled receptors in human fat taste perception. Chem Senses 2012, 37(2):123-139.
22. Simons P.J., Kummer J.A., Luiken J.J., Boon L. Apical CD36 immunolocalization in human and porcine taste buds from circumvallate and foliate papillae. Acta Histochem 2011, 113(8):839-843.
23. El-Yassimi A., Hichami A., Besnard P., Khan N.A. Linoleic acid induces calcium signaling, Src kinase phosphorylation, and neurotransmitter release in mouse CD36-positive gustatory cells. J Biol Chem 2008, 283(19):12949-12959.
24. Baillie A.G., Coburn C.T., Abumrad N.A. Reversible binding of long-chain fatty acids to purified FAT, the adipose CD36 homolog. J Membr Biol 1996, 153(1):75-81.
25. Dramane G., Abdoul-Azize S., Hichami A., Vogtle T., Akpona S., Chouabe C., et al. STIM1 regulates calcium signaling in taste bud cells and preference for fat in mice. J Clin Invest 2012, 122(6):2267-2282.
26. Sclafani A., Ackroff K., Abumrad N.A. CD36 gene deletion reduces fat preference and intake but not post-oral fat conditioning in mice. Am J Physiol Regul Integr Comp Physiol 2007, 293(5):R1823-R1832.
27. Martin C., Passilly-Degrace P., Gaillard D., Merlin J.F., Chevrot M., Besnard P. The lipid-sensor candidates CD36 and GPR120 are differentially regulated by dietary lipids in mouse taste buds: impact on spontaneous fat preference. PLoS One 2011, 6(8):e24014.
28. Cartoni C., Yasumatsu K., Ohkuri T., Shigemura N., Yoshida R., Godinot N., et al. Taste preference for fatty acids is mediated by GPR40 and GPR120. J Neurosci 2010, 30(25):8376-8382.
29. Shin Y.K., Martin B., Golden E., Dotson C.D., Maudsley S., Kim W., et al. Modulation of taste sensitivity by GLP-1 signaling. J Neurochem 2008, 106(1):455-463.
30. Martin C., Passilly-Degrace P., Chevrot M., Ancel D., Sparks S.M., Drucker D.J., et al. Lipid-mediated release of GLP-1 by mouse taste buds from circumvallate papillae: putative involvement of GPR120 and impact on taste sensitivity. J Lipid Res 2012, 53(11):2256-2265.
31. Mattes R.D. Oral fat exposure alters postprandial lipid metabolism in humans. Am J Clin Nutr 1996, 63(6):911-917.
32. Mattes R.D. The taste of fat elevates postprandial triacylglycerol. Physiol Behav 2001, 74(3):343-348.
33. Smeets A.J., Westerterp-Plantenga M.S. Satiety and substrate mobilization after oral fat stimulation. Br J Nutr 2006, 95(4):795-801.
34. Heath R.B., Jones R., Frayn K.N., Robertson M.D. Vagal stimulation exaggerates the inhibitory ghrelin response to oral fat in humans. J Endocrinol 2004, 180(2):273-281.
35. Hiraoka T., Fukuwatari T., Imaizumi M., Fushiki T. Effects of oral stimulation with fats on the cephalic phase of pancreatic enzyme secretion in esophagostomized rats. Physiol Behav 2003, 79(4-5):713-717.
36. Wisen O., Bjorvell H., Cantor P., Johansson C., Theodorsson E. Plasma concentrations of regulatory peptides in obesity following modified sham feeding (MSF) and a liquid test meal. Regul Pept 1992, 39(1):43-54.
37. Wojdemann M., Traberg P., Stadil F., Sternby B., Larsen S., Hilsted L., et al. Effect of sham feeding and acute suppression of acid secretion on human gastric lipase secretion. Am J Gastroenterol 1998, 93(2):244-248.
38. Smeets A.J., Lejeune M.P., Westerterp-Plantenga M.S. Effects of oral fat perception by modified sham feeding on energy expenditure, hormones and appetite profile in the postprandial state. Br J Nutr 2009, 101(9):1360-1368.
39. Margolskee R.F., Dyer J., Kokrashvili Z., Salmon K.S., Ilegems E., Daly K., et al. T1R3 and gustducin in gut sense sugars to regulate expression of Na+-glucose cotransporter 1. Proc Natl Acad Sci USA 2007, 104(38):15075-15080.
40. Liou A.P., Lu X., Sei Y., Zhao X., Pechhold S., Carrero R.J., et al. The G-protein-coupled receptor GPR40 directly mediates long-chain fatty acid-induced secretion of cholecystokinin. Gastroenterology 2010, 140(3):903-912.
41. Hirasawa A., Tsumaya K., Awaji T., Katsuma S., Adachi T., Yamada M., et al. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 2005, 11(1):90-94.
42. Karaki S., Mitsui R., Hayashi H., Kato I., Sugiya H., Iwanaga T., et al. Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine. Cell Tissue Res 2006, 324(3):353-360.
43. Lan H., Vassileva G., Corona A., Liu L., Baker H., Golovko A., et al. GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis. J Endocrinol 2009, 201(2):219-230.
44. Samuel B.S., Shaito A., Motoike T., Rey F.E., Backhed F., Manchester J.K., et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci 2008, 105(43):16767-16772.
45. Hardy S., St-Onge G.G., Joly E., Langelier Y., Prentki M. Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40. J Biol Chem 2005, 280(14):13285-13291.
46. Briscoe C.P., Tadayyon M., Andrews J.L., Benson W.G., Chambers J.K., Eilert M.M., et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem 2003, 278(13):11303-11311.
47. Reimann F., Tolhurst G., Gribble F.M. G-protein-coupled receptors in intestinal chemosensation. Cell Metab 2012, 15(4):421-431.
48. Edfalk S., Steneberg P., Edlund H. Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion. Diabetes 2008, 57(9):2280-2287.
49. Shah B.P., Liu P., Yu T., Hansen D.R., Gilbertson T.A. TRPM5 is critical for linoleic acid-induced CCK secretion from the enteroendocrine cell line, STC-1. Am J Physiol Cell Physiol 2012, 302(1):C210-C219.
50. Chu Z.L., Carroll C., Alfonso J., Gutierrez V., He H., Lucman A., et al. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like peptide-1 and glucose-dependent insulinotropic peptide release. Endocrinology 2008, 149(5):2038-2047.
51. Sykaras A.G., Demenis C., Case R.M., McLaughlin J.T., Smith C.P. Duodenal enteroendocrine I-cells contain mRNA transcripts encoding key endocannabinoid and fatty acid receptors. PLoS One 2012, 7(8):e42373.
52. Hansen K.B., Rosenkilde M.M., Knop F.K., Wellner N., Diep T.A., Rehfeld J.F., et al. 2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans. J Clin Endocrinol Metab 2011, 96(9):E1409-E1417.
53. Lauffer L.M., Iakoubov R., Brubaker P.L. GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. Diabetes 2009, 58(5):1058-1066.
54. Flock G., Holland D., Seino Y., Drucker D.J. GPR119 regulates murine glucose homeostasis through incretin receptor-dependent and independent mechanisms. Endocrinology 2010, 152(2):374-383.
55. Tolhurst G., Heffron H., Lam Y.S., Parker H.E., Habib A.M., Diakogiannaki E., et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 2012, 61(2):364-371.
56. Martin C., Chevrot M., Poirier H., Passilly-Degrace P., Niot I., Besnard P. CD36 as a lipid sensor. Physiol Behav 2011, 105(1):36-42.
57. Nassir F., Wilson B., Han X., Gross R.W., Abumrad N.A. CD36 is important for fatty acid and cholesterol uptake by the proximal but not distal intestine. J Biol Chem 2007, 282(27):19493-19501.
58. Drover V.A., Ajmal M., Nassir F., Davidson N.O., Nauli A.M., Sahoo D., et al. CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood. J Clin Invest 2005, 115(5):1290-1297.
59. Goudriaan J.R., Dahlmans V.E.H., Febbraio M., Teusink B., Romijn J.A., Havekes L.M., et al. Intestinal lipid absorption is not affected in CD36 deficient mice. Mol Cell Biochem 2002, 239(1):199-202.
60. Lynes M.D., Widmaier E.P. Involvement of CD36 and intestinal alkaline phosphatases in fatty acid transport in enterocytes, and the response to a high-fat diet. Life Sci 2011, 88(9-10):384-391.
61. Guijarro A., Fu J., Astarita G., Piomelli D. CD36 gene deletion decreases oleoylethanolamide levels in small intestine of free-feeding mice. Pharmacol Res 2010, 61(1):27-33.
62. Schwartz G.J., Fu J., Astarita G., Li X., Gaetani S., Campolongo P., et al. The lipid messenger OEA links dietary fat intake to satiety. Cell Metab 2008, 8(4):281-288.
63. Naville D., Duchampt A., Vigier M., Oursel D., Lessire R., Poirier H., et al. Link between intestinal CD36 ligand binding and satiety induced by a high protein diet in mice. PLoS One 2012, 7(1):e30686.
64. Iakoubov R., Ahmed A., Lauffer L.M., Bazinet R.P., Brubaker P.L. Essential role for protein kinase Czeta in oleic acid-induced glucagon-like peptide-1 secretion in vivo in the rat. Endocrinology 2011, 152(4):1244-1252.
65. Sundaresan S., Shahid R., Riehl T.E., Chandra R., Nassir F., Stenson W.F., et al. CD36-dependent signaling mediates fatty acid-induced gut release of secretin and cholecystokinin. FASEB J 2013, 27(3):1191-1202.
66. Poreba M.A., Dong C.X., Li S.K., Stahl A., Miner J.H., Brubaker P.L. Role of fatty acid transport protein 4 in oleic acid-induced glucagon-like peptide-1 secretion from murine intestinal L cells. Am J Physiol Endocrinol Metab 2012, 303(7):E899-E907.
67. Zhang X.J., Zhou L.H., Ban X., Liu D.X., Jiang W., Liu X.M. Decreased expression of CD36 in circumvallate taste buds of high-fat diet induced obese rats. Acta Histochem 2011, 113(6):663-667.
68. Stewart J.E., Keast R.S. Recent fat intake modulates fat taste sensitivity in lean and overweight subjects. Int J Obes (Lond) 2011, 36(6):834-842.
69. Stewart J.E., Newman L.P., Keast R.S. Oral sensitivity to oleic acid is associated with fat intake and body mass index. Clin Nutr 2011, 30(6):838-844.
70. Shin A.C., Berthoud H.R. Food reward functions as affected by obesity and bariatric surgery. Int J Obes (Lond) 2011, 35(Suppl 3):S40-S44.
71. Shin A.C., Townsend R.L., Patterson L.M., Berthoud H.R. "Liking" and "wanting" of sweet and oily food stimuli as affected by high-fat diet-induced obesity, weight loss, leptin, and genetic predisposition. Am J Physiol Regul Integr Comp Physiol 2011, 301(5):R1267-R1280.
72. Swartz T.D., Savastano D.M., Covasa M. Reduced sensitivity to cholecystokinin in male rats fed a high-fat diet is reversible. J Nutr 2010, 140(9):1698-1703.
73. Berthoud H.R., Lenard N.R., Shin A.C. Food reward, hyperphagia, and obesity. Am J Physiol Regul Integr Comp Physiol 2011, 300(6):R1266-R1277.
74. Burger K.S., Stice E. Variability in reward responsivity and obesity: evidence from brain imaging studies. Curr Drug Abuse Rev 2011, 4(3):182-189.
75. Duca F.A., Swartz T.D., Sakar Y., Covasa M. Decreased intestinal nutrient response in diet-induced obese rats: role of gut peptides and nutrient receptors. Int J Obes (Lond) 2012, 37(3):375-381.
76. Blundell J.E., Lawton C.L., Cotton J.R., Macdiarmid J.I. Control of human appetite: implications for the intake of dietary fat. Annu Rev Nutr 1996, 16:285-319.
77. Covasa M., Grahn J., Ritter R.C. High fat maintenance diet attenuates hindbrain neuronal response to CCK. Regul Pept 2000, 86(1-3):83-88.
78. Covasa M., Ritter R.C. Adaptation to high-fat diet reduces inhibition of gastric emptying by CCK and intestinal oleate. Am J Physiol Regul Integr Comp Physiol 2000, 278(1):R166-R170.
79. Donovan M.J., Paulino G., Raybould H.E. Activation of hindbrain neurons in response to gastrointestinal lipid is attenuated by high fat, high energy diets in mice prone to diet-induced obesity. Brain Res 2009, 1248:136-140.
80. Savastano D.M., Covasa M. Adaptation to a high-fat diet leads to hyperphagia and diminished sensitivity to cholecystokinin in rats. J Nutr 2005, 135(8):1953-1959.
81. Paulino G., Darcel N., Tome D., Raybould H. Adaptation of lipid-induced satiation is not dependent on caloric density in rats. Physiol Behav 2008, 93(4-5):930-936.
82. Lissner L., Levitsky D.A., Strupp B.J., Kalkwarf H.J., Roe D.A. Dietary fat and the regulation of energy intake in human subjects. Am J Clin Nutr 1987, 46(6):886-892.
83. French S.J., Murray B., Rumsey R.D., Fadzlin R., Read N.W. Adaptation to high-fat diets: effects on eating behaviour and plasma cholecystokinin. Br J Nutr 1995, 73(2):179-189.
84. Boyd K.A., O'Donovan D.G., Doran S., Wishart J., Chapman I.M., Horowitz M., et al. High-fat diet effects on gut motility, hormone, and appetite responses to duodenal lipid in healthy men. Am J Physiol Gastrointest Liver Physiol 2003, 284(2):G188-G196.
85. Covasa M., Ritter R.C. Reduced sensitivity to the satiation effect of intestinal oleate in rats adapted to high-fat diet. Am J Physiol 1999, 277(1 Pt 2):R279-R285.
86. Lucas F., Sclafani A. The composition of the maintenance diet alters flavor-preference conditioning by intragastric fat infusions in rats. Physiol Behav 1996, 60(4):1151-1157.
87. Woods S.C., Seeley R.J., Rushing P.A., D'Alessio D., Tso P. A controlled high-fat diet induces an obese syndrome in rats. J Nutr 2003, 133(4):1081-1087.
88. Covasa M. Deficits in gastrointestinal responses controlling food intake and body weight. Am J Physiol Regul Integr Comp Physiol 2010, 299(6):R1423-R1439.
89. Balint J.A., Fried M.B., Imai C. Ileal uptake of oleic acid: evidence for adaptive response to high fat feeding. Am J Clin Nutr 1980, 33(11):2276-2280.
90. Singh A., Balint J.A., Edmonds R.H., Rodgers J.B. Adaptive changes of the rat small intestine in response to a high fat diet. Biochim Biophys Acta 1972, 260(4):708-715.
91. Sabb J.E., Godfrey P.M., Brannon P.M. Adaptive response of rat pancreatic lipase to dietary fat: effects of amount and type of fat. J Nutr 1986, 116(5):892-899.
92. Brenner L.A., Covasa M., Ritter R.C. Dietary adaptation increases digestive capacity and decreases satiety response to macronutrients (Abstract). Abstr Soc Neurosci 1997, 23(1):1.
93. Yoshioka M., Bolduc C., Raymond V., St-Amand J. High-fat meal-induced changes in the duodenum mucosa transcriptome. Obesity (Silver Spring) 2008, 16(10):2302-2307.
94. de Wit N.J., Bosch-Vermeulen H., de Groot P.J., Hooiveld G.J., Bromhaar M.M., Jansen J., et al. The role of the small intestine in the development of dietary fat-induced obesity and insulin resistance in C57BL/6J mice. BMC Med Genomics 2008, 1:14.
95. de Wit N.J., Boekschoten M.V., Bachmair E.M., Hooiveld G.J., de Groot P.J., Rubio-Aliaga I., et al. Dose-dependent effects of dietary fat on development of obesity in relation to intestinal differential gene expression in C57BL/6J mice. PLoS One 2011, 6(4):e19145.
96. Goda T., Takase S. Effect of dietary fat content on microvillus in rat jejunum. J Nutr Sci Vitaminol (Tokyo) 1994, 40(2):127-136.
97. De Barros Alencar A.C.M., Neves R.H., De Oliveira A.V., Machado-Silva J.R. Changes in the small intestine of Schistosoma mansoni-infected mice fed a high-fat diet. Parasitology 2011, 139(06):716-725.
98. Scoaris C.R., Rizo G.V., Roldi L.P., de Moraes S.M., de Proenca A.R., Peralta R.M., et al. Effects of cafeteria diet on the jejunum in sedentary and physically trained rats. Nutrition 2010, 26(3):312-320.
99. Baldassano S., Amato A., Cappello F., Rappa F., Mule F. Glucagon-like peptide-2 and mouse intestinal adaptation to a high fat diet. J Endocrinol 2013, 217(1):11-20.
100. Gniuli D., Calcagno A., Dalla Libera L., Calvani R., Leccesi L., Caristo M.E., et al. High-fat feeding stimulates endocrine, glucose-dependent insulinotropic polypeptide (GIP)-expressing cell hyperplasia in the duodenum of Wistar rats. Diabetologia 2010, 53(10):2233-2240.
101. Mumphrey M.B., Patterson L.M., Zheng H., Berthoud H.R. Roux-en-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin-expressing enteroendocrine cells in rats. Neurogastroenterol Motil 2013, 25(1):e70-e79.
102. Hyland N.P., Pittman Q.J., Sharkey K.A. Peptide YY containing enteroendocrine cells and peripheral tissue sensitivity to PYY and PYY(3-36) are maintained in diet-induced obese and diet-resistant rats. Peptides 2007, 28(6):1185-1190.
103. Duca F.A., Sakar Y., Covasa M. Combination of obesity and high-fat feeding diminishes sensitivity to GLP-1R agonist, Exendin-4. Diabetes 2013, 62(7):2410-2415.
104. Everard A., Lazarevic V., Derrien M., Girard M., Muccioli G.M., Neyrinck A.M., et al. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 2011, 60(11):2775-2786.
105. Brown N.J., Rumsey R.D., Read N.W. Gastrointestinal adaptation to enhanced small intestinal lipid exposure. Gut 1994, 35(10):1409-1412.
106. Cunningham K.M., Daly J., Horowitz M., Read N.W. Gastrointestinal adaptation to diets of differing fat composition in human volunteers. Gut 1991, 32(5):483-486.
107. Castiglione K.E., Read N.W., French S.J. Adaptation to high-fat diet accelerates emptying of fat but not carbohydrate test meals in humans. Am J Physiol Regul Integr Comp Physiol 2002, 282(2):R366-R371.
108. Clegg M.E., McKenna P., McClean C., Davison G.W., Trinick T., Duly E., et al. Gastrointestinal transit, post-prandial lipaemia and satiety following 3 days high-fat diet in men. Eur J Clin Nutr 2010, 65(2):240-246.
109. Reed D.R., Tordoff M.G., Friedman M.I. Enhanced acceptance and metabolism of fats by rats fed a high-fat diet. Am J Physiol 1991, 261(5 Pt 2):R1084-R1088.
110. Lin H.C., Doty J.E., Reedy T.J., Meyer J.H. Inhibition of gastric emptying by sodium oleate depends on length of intestine exposed to nutrient. Am J Physiol 1990, 259(6 Pt 1):G1031-G1036.
111. Lin H.C., Doty J.E., Reedy T.J., Meyer J.H. Inhibition of gastric emptying by glucose depends on length of intestine exposed to nutrient. Am J Physiol 1989, 256(2 Pt 1):G404-G411.
112. Blundell J.E., Levin F., King N.A., Barkeling B., Gustafsson T., Hellstrom P.M., et al. Overconsumption and obesity: peptides and susceptibility to weight gain. Regul Pept 2008, 149(1-3):32-38.
113. Woods S.C. Signals that influence food intake and body weight. Physiol Behav 2005, 86(5):709-716.
114. Woods S.C. The control of food intake: behavioral versus molecular perspectives. Cell Metab 2009, 9(6):489-498.
115. Covasa M., Marcuson J.K., Ritter R.C. Diminished satiation in rats exposed to elevated levels of endogenous or exogenous cholecystokinin. Am J Physiol Regul Integr Comp Physiol 2001, 280(2):R331-R337.
116. Covasa M., Ritter R.C. Rats maintained on high-fat diets exhibit reduced satiety in response to CCK and bombesin. Peptides 1998, 19(8):1407-1415.
117. Nefti W., Chaumontet C., Fromentin G., Tome D., Darcel N. A high-fat diet attenuates the central response to within-meal satiation signals and modifies the receptor expression of vagal afferents in mice. Am J Physiol Regul Integr Comp Physiol 2009, 296(6):R1681-R1686.
118. Little T.J., Feltrin K.L., Horowitz M., Meyer J.H., Wishart J., Chapman I.M., et al. A high-fat diet raises fasting plasma CCK but does not affect upper gut motility, PYY, and ghrelin, or energy intake during CCK-8 infusion in lean men. Am J Physiol Regul Integr Comp Physiol 2008, 294(1):R45-R51.
119. Spannagel A.W., Nakano I., Tawil T., Chey W.Y., Liddle R.A., Green G.M. Adaptation to fat markedly increases pancreatic secretory response to intraduodenal fat in rats. Am J Physiol 1996, 270(1 Pt 1):G128-G135.
120. Daly D.M., Park S.J., Valinsky W.C., Beyak M.J. Impaired intestinal afferent nerve satiety signalling and vagal afferent excitability in diet induced obesity in the mouse. J Physiol 2011, 589(Pt 11):2857-2870.
121. Williams D.L., Hyvarinen N., Lilly N., Kay K., Dossat A., Parise E., et al. Maintenance on a high-fat diet impairs the anorexic response to glucagon-like-peptide-1 receptor activation. Physiol Behav 2011, 103(5):557-564.
122. Anini Y., Brubaker P.L. Role of leptin in the regulation of glucagon-like peptide-1 secretion. Diabetes 2003, 52(2):252-259.
123. Naslund E., Gryback P., Backman L., Jacobsson H., Holst J.J., Theodorsson E., et al. Distal small bowel hormones: correlation with fasting antroduodenal motility and gastric emptying. Dig Dis Sci 1998, 43(5):945-952.
124. Rask E., Olsson T., Soderberg S., Johnson O., Seckl J., Holst J.J., et al. Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men. Diabetes Care 2001, 24(9):1640-1645.
125. Hayes M.R., Kanoski S.E., Alhadeff A.L., Grill H.J. Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats. Obesity (Silver Spring) 2011, 19(7):1342-1349.
126. Verdich C., Flint A., Gutzwiller J.P., Naslund E., Beglinger C., Hellstrom P.M., et al. A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab 2001, 86(9):4382-4389.
127. le Roux C.W., Batterham R.L., Aylwin S.J., Patterson M., Borg C.M., Wynne K.J., et al. Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 2006, 147(1):3-8.
128. Guo Y., Ma L., Enriori P.J., Koska J., Franks P.W., Brookshire T., et al. Physiological evidence for the involvement of peptide YY in the regulation of energy homeostasis in humans. Obesity (Silver Spring) 2006, 14(9):1562-1570.
129. Vrang N., Madsen A.N., Tang-Christensen M., Hansen G., Larsen P.J. PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 2006, 291(2):R367-R375.
130. Batterham R.L., Cohen M.A., Ellis S.M., Le Roux C.W., Withers D.J., Frost G.S., et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 2003, 349(10):941-948.
131. Adams S.H., Lei C., Jodka C.M., Nikoulina S.E., Hoyt J.A., Gedulin B., et al. PYY[3-36] administration decreases the respiratory quotient and reduces adiposity in diet-induced obese mice. J Nutr 2006, 136(1):195-201.
132. Challis B.G., Coll A.P., Yeo G.S., Pinnock S.B., Dickson S.L., Thresher R.R., et al. Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36). Proc Natl Acad Sci USA 2004, 101(13):4695-4700.
133. Chelikani P.K., Haver A.C., Reidelberger R.D. Intermittent intraperitoneal infusion of peptide YY(3-36) reduces daily food intake and adiposity in obese rats. Am J Physiol Regul Integr Comp Physiol 2007, 293(1):R39-R46.
134. Briggs D.I., Enriori P.J., Lemus M.B., Cowley M.A., Andrews Z.B. Diet-induced obesity causes ghrelin resistance in arcuate NPY/AgRP neurons. Endocrinology 2010, 151(10):4745-4755.
135. Beck B., Musse N., Stricker-Krongrad A. Ghrelin, macronutrient intake and dietary preferences in long-evans rats. Biochem Biophys Res Commun 2002, 292(4):1031-1035.
136. Handjieva-Darlenska T., Boyadjieva N. The effect of high-fat diet on plasma ghrelin and leptin levels in rats. J Physiol Biochem 2009, 65(2):157-164.
137. Lee H.M., Wang G., Englander E.W., Kojima M., Greeley G.H. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology 2002, 143(1):185-190.
138. Wang X., Ni S., Xu Y., Liang L., Du L., Gu W. Effects of long-term high-fat/high-energy and high-protein diets on insulin and ghrelin expression in developing rats. Endocr Res 2012, 37(3):97-109.
139. Gomez G., Han S., Englander E.W., Greeley G.H. Influence of a long-term high-fat diet on ghrelin secretion and ghrelin-induced food intake in rats. Regul Pept 2012, 173(1-3):60-63.
140. Qi X., Reed J.T., Wang G., Han S., Englander E.W., Greeley G.H. Ghrelin secretion is not reduced by increased fat mass during diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 2008, 295(2):R429-R435.
141. Tassone F., Broglio F., Destefanis S., Rovere S., Benso A., Gottero C., et al. Neuroendocrine and metabolic effects of acute ghrelin administration in human obesity. J Clin Endocrinol Metab 2003, 88(11):5478-5483.
142. Robertson M.D., Henderson R.A., Vist G.E., Rumsey R.D. Plasma ghrelin response following a period of acute overfeeding in normal weight men. Int J Obes Relat Metab Disord 2004, 28(6):727-733.
143. Ochner C.N., Gibson C., Shanik M., Goel V., Geliebter A. Changes in neurohormonal gut peptides following bariatric surgery. Int J Obes (Lond) 2011, 35(2):153-166.
144. Dailey M.J., Moghadam A.A., Moran T.H. Jejunal linoleic acid infusions require GLP-1 receptor signaling to inhibit food intake: implications for the effectiveness of Roux-en-Y gastric bypass. Am J Physiol Endocrinol Metab 2011, 301(6):E1184-E1190.
145. Brennan I.M., Luscombe-Marsh N.D., Seimon R.V., Otto B., Horowitz M., Wishart J.M., et al. Effects of fat, protein, and carbohydrate and protein load on appetite, plasma cholecystokinin, peptide YY, and ghrelin, and energy intake in lean and obese men. Am J Physiol Gastrointest Liver Physiol 2012, 303(1):G129-G140.
146. Duca F.A., Covasa M. Current and emerging concepts on the role of peripheral signals in the control of food intake and development of obesity. Br J Nutr 2012, 1-16.
147. Greenwood H.C., Bloom S.R., Murphy K.G. Peptides and their potential role in the treatment of diabetes and obesity. Rev Diabet Stud 2011, 8(3):355-368.
148. Neary M.T., Batterham R.L. Gut hormones: implications for the treatment of obesity. Pharmacol Ther 2009, 124(1):44-56.
149. Abdelmoumene S., Gardner J.D. Cholecystokinin-induced desensitization of enzyme secretion in dispersed acini from guinea pig pancreas. Am J Physiol 1980, 239(4):G272-G279.
150. McLaughlin C.L., Peikin S.R., Baile C.A. Decreased pancreatic CCK receptor binding and CCK-stimulated amylase release in Zucker obese rats. Physiol Behav 1984, 32(6):961-965.
151. Niederau C., Meereis-Schwanke K., Klonowski-Stumpe H., Herberg L. CCK-resistance in Zucker obese versus lean rats. Regul Pept 1997, 70(2-3):97-104.
152. Broberger C., Holmberg K., Shi T.J., Dockray G., Hokfelt T. Expression and regulation of cholecystokinin and cholecystokinin receptors in rat nodose and dorsal root ganglia. Brain Res 2001, 903(1-2):128-140.
153. Burdyga G., Spiller D., Morris R., Lal S., Thompson D.G., Saeed S., et al. Expression of the leptin receptor in rat and human nodose ganglion neurones. Neuroscience 2002, 109(2):339-347.
154. de Lartigue G., Barbier de la Serre C., Espero E., Lee J., Raybould H.E. Leptin resistance in vagal afferent neurons inhibits cholecystokinin signaling and satiation in diet induced obese rats. PLoS One 2012, 7(3):e32967.
155. Matson C.A., Reid D.F., Cannon T.A., Ritter R.C. Cholecystokinin and leptin act synergistically to reduce body weight. Am J Physiol Regul Integr Comp Physiol 2000, 278(4):R882-R890.
156. Peters J.H., Karpiel A.B., Ritter R.C., Simasko S.M. Cooperative activation of cultured vagal afferent neurons by leptin and cholecystokinin. Endocrinology 2004, 145(8):3652-3657.
157. McLaughlin C.L., Baile C.A. Cholecystokinin, amphetamine and diazepam and feeding in lean and obese Zucker rats. Pharmacol Biochem Behav 1979, 10(1):87-93.
158. McLaughlin C.L., Baile C.A. Feeding response of weanling Zucker obese rats to cholecystokinin and bombesin. Physiol Behav 1980, 25(3):341-346.
159. McLaughlin C.L., Baile C.A. Obese mice and the satiety effects of cholecystokinin, bombesin and pancreatic polypeptide. Physiol Behav 1981, 26(3):433-437.
160. Strohmayer A.J., Smith G.P. Obese male mice (ob/ob) are normally sensitive to the satiating effect of CCK-8. Brain Res Bull 1986, 17(4):571-573.
161. de Lartigue G., Barbier de la Serre C., Espero E., Lee J., Raybould H.E. Diet-induced obesity leads to the development of leptin resistance in vagal afferent neurons. Am J Physiol Endocrinol Metab 2011, 301(1):E187-E195.
162. Levin B.E., Dunn-Meynell A.A., Balkan B., Keesey R.E. Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats. Am J Physiol 1997, 273(2 Pt 2):R725-R730.
163. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56(7):1761-1772.
164. Funakoshi A., Miyasaka K., Matsumoto H., Yamamori S., Takiguchi S., Kataoka K., et al. Gene structure of human cholecystokinin (CCK) type-A receptor: body fat content is related to CCK type-A receptor gene promoter polymorphism. FEBS Lett 2000, 466(2-3):264-266.
165. de Krom M., van der Schouw Y.T., Hendriks J., Ophoff R.A., van Gils C.H., Stolk R.P., et al. Common genetic variations in CCK, leptin, and leptin receptor genes are associated with specific human eating patterns. Diabetes 2007, 56(1):276-280.
166. French S.J., Murray B., Rumsey R.D., Sepple C.P., Read N.W. Preliminary studies on the gastrointestinal responses to fatty meals in obese people. Int J Obes Relat Metab Disord 1993, 17(5):295-300.
167. Batt R.A. Decreased food intake in response to cholecystokinin (pancreozymin) in wild-type and obese mice (genotype ob/ob). Int J Obes 1983, 7(1):25-29.
168. Bellinger L.L., Bernardis L.L. Suppression of feeding by cholecystokinin but not bombesin is attenuated in dorsomedial hypothalamic nuclei lesioned rats. Peptides 1984, 5(3):547-552.
169. Swartz T.D., Duca F.A., Covasa M. Differential feeding behavior and neuronal responses to CCK in obesity-prone and -resistant rats. Brain Res 2010, 1308:79-86.
170. Holst J.J., Orskov C., Nielsen O.V., Schwartz T.W. Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut. FEBS Lett 1987, 211(2):169-174.
171. Mojsov S., Weir G.C., Habener J.F. Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 1987, 79(2):616-619.
172. Phillips L.K., Prins J.B. Update on incretin hormones. Ann N Y Acad Sci 2011, 1243:E55-E74.
173. Hayes M.R., Bradley L., Grill H.J. Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling. Endocrinology 2009, 150(6):2654-2659.
174. Williams D.L., Baskin D.G., Schwartz M.W. Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety. Endocrinology 2009, 150(4):1680-1687.
175. le Roux C.W., Borg C., Wallis K., Vincent R.P., Bueter M., Goodlad R., et al. Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation. Ann Surg 2010, 252(1):50-56.
176. Cani P.D., Possemiers S., Van de Wiele T., Guiot Y., Everard A., Rottier O., et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009, 58(8):1091-1103.
177. Lugari R., Dei Cas A., Ugolotti D., Barilli A.L., Camellini C., Ganzerla G.C., et al. Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion. Horm Metab Res 2004, 36(2):111-115.
178. Carr R.D., Larsen M.O., Jelic K., Lindgren O., Vikman J., Holst J.J., et al. Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men. J Clin Endocrinol Metab 2010, 95(2):872-878.
179. Vilsboll T., Agerso H., Krarup T., Holst J.J. Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects. J Clin Endocrinol Metab 2003, 88(1):220-224.
180. Nayak U.A., Govindan J., Baskar V., Kalupahana D., Singh B.M. Exenatide therapy in insulin-treated type 2 diabetes and obesity. QJM 2010, 103(9):687-694.
181. Abu-Hamdah R., Rabiee A., Meneilly G.S., Shannon R.P., Andersen D.K., Elahi D. Clinical review: The extrapancreatic effects of glucagon-like peptide-1 and related peptides. J Clin Endocrinol Metab 2009, 94(6):1843-1852.
182. Deacon C.F., Pridal L., Klarskov L., Olesen M., Holst J.J. Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig. Am J Physiol 1996, 271(3 Pt 1):E458-E464.
183. Kastin A.J., Akerstrom V. Entry of exendin-4 into brain is rapid but may be limited at high doses. Int J Obes Relat Metab Disord 2003, 27(3):313-318.
184. Hayes M.R., De Jonghe B.C., Kanoski S.E. Role of the glucagon-like-peptide-1 receptor in the control of energy balance. Physiol Behav 2010, 100(5):503-510.
185. Vahl T.P., Tauchi M., Durler T.S., Elfers E.E., Fernandes T.M., Bitner R.D., et al. Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. Endocrinology 2007, 148(10):4965-4973.
186. Bucinskaite V., Tolessa T., Pedersen J., Rydqvist B., Zerihun L., Holst J.J., et al. Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat. Neurogastroenterol Motil 2009, 21(9):978-e78.
187. Abbott C.R., Monteiro M., Small C.J., Sajedi A., Smith K.L., Parkinson J.R., et al. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 2005, 1044(1):127-131.
188. Talsania T., Anini Y., Siu S., Drucker D.J., Brubaker P.L. Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice. Endocrinology 2005, 146(9):3748-3756.
189. Kanoski S.E., Fortin S.M., Arnold M., Grill H.J., Hayes M.R. Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4. Endocrinology 2011, 152(8):3103-3112.
190. Browning K., Fortna S.R., Hajnal A. Roux-en-Y Gastric Bypass reverses the effects of diet-induced obesity to inhibit the responsiveness of central vagal motoneurones. J Physiol 2013, 591(Pt 9):2357-2372.
191. Williams D.L., Baskin D.G., Schwartz M.W. Leptin regulation of the anorexic response to glucagon-like peptide-1 receptor stimulation. Diabetes 2006, 55(12):3387-3393.
192. Zhao S., Kanoski S.E., Yan J., Grill H.J., Hayes M.R. Hindbrain leptin and glucagon-like-peptide-1 receptor signaling interact to suppress food intake in an additive manner. Int J Obes (Lond) 2012, 36(12):1522-1528.
193. Adrian T.E., Ferri G.L., Bacarese-Hamilton A.J., Fuessl H.S., Polak J.M., Bloom S.R. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 1985, 89(5):1070-1077.
194. Grandt D., Schimiczek M., Beglinger C., Layer P., Goebell H., Eysselein V.E., et al. Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept 1994, 51(2):151-159.
195. Grandt D., Schimiczek M., Struk K., Shively J., Eysselein V.E., Goebell H., et al. Characterization of two forms of peptide YY, PYY(1-36) and PYY(3-36), in the rabbit. Peptides 1994, 15(5):815-820.
196. Mentlein R., Gallwitz B., Schmidt W.E. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem 1993, 214(3):829-835.
197. Koda S., Date Y., Murakami N., Shimbara T., Hanada T., Toshinai K., et al. The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology 2005, 146(5):2369-2375.
198. Moran T.H., Dailey M.J. Intestinal feedback signaling and satiety. Physiol Behav 2011, 105(1):77-81.
199. Chandarana K., Gelegen C., Karra E., Choudhury A.I., Drew M.E., Fauveau V., et al. Diet and gastrointestinal bypass-induced weight loss: the roles of Ghrelin and peptide YY. Diabetes 2011, 60(3):810-818.
200. Shin A.C., Zheng H., Townsend R.L., Sigalet D.L., Berthoud H.R. Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery. Endocrinology 2010, 151(4):1588-1597.
201. Huang X.F., Yu Y., Li Y., Tim S., Deng C., Wang Q. Ventromedial hypothalamic NPY Y2 receptor in the maintenance of body weight in diet-induced obesity in mice. Neurochem Res 2008, 33(9):1881-1888.
202. Li J., Ma W., Wang S. Slower gastric emptying in high-fat diet induced obese rats is associated with attenuated plasma ghrelin and elevated plasma leptin and cholecystokinin concentrations. Regul Pept 2011, 171(1-3):53-57.
203. Field B.C.T., Wren A.M., Peters V., Baynes K.C.R., Martin N.M., Patterson M., et al. PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans. Diabetes 2010, 59(7):1635-1639.
204. Rahardjo G.L., Huang X.F., Tan Y.Y., Deng C. Decreased plasma peptide YY accompanied by elevated peptide YY and Y2 receptor binding densities in the medulla oblongata of diet-induced obese mice. Endocrinology 2007, 148(10):4704-4710.
205. Date Y., Kojima M., Hosoda H., Sawaguchi A., Mondal M.S., Suganuma T., et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000, 141(11):4255-4261.
206. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402(6762):656-660.
207. Tschop M., Smiley D.L., Heiman M.L. Ghrelin induces adiposity in rodents. Nature 2000, 407(6806):908-913.
208. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001, 86(12):5992.
209. Wren A.M., Small C.J., Abbott C.R., Dhillo W.S., Seal L.J., Cohen M.A., et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001, 50(11):2540-2547.
210. Cummings D.E., Frayo R.S., Marmonier C., Aubert R., Chapelot D. Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues. Am J Physiol Endocrinol Metab 2004, 287(2):E297-E304.
211. Cummings D.E., Purnell J.Q., Frayo R.S., Schmidova K., Wisse B.E., Weigle D.S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001, 50(8):1714-1719.
212. Tamura H., Kamegai J., Shimizu T., Ishii S., Sugihara H., Oikawa S. Ghrelin stimulates GH but not food intake in arcuate nucleus ablated rats. Endocrinology 2002, 143(9):3268-3275.
213. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., et al. A role for ghrelin in the central regulation of feeding. Nature 2001, 409(6817):194-198.
214. Chen H.Y., Trumbauer M.E., Chen A.S., Weingarth D.T., Adams J.R., Frazier E.G., et al. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 2004, 145(6):2607-2612.
215. le Roux C.W., Neary N.M., Halsey T.J., Small C.J., Martinez-Isla A.M., Ghatei M.A., et al. Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. J Clin Endocrinol Metab 2005, 90(8):4521-4524.
216. Date Y., Murakami N., Toshinai K., Matsukura S., Niijima A., Matsuo H., et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002, 123(4):1120-1128.
217. Asakawa A., Inui A., Kaga T., Katsuura G., Fujimiya M., Fujino M.A., et al. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 2003, 52(7):947-952.
218. Shearman L.P., Wang S.P., Helmling S., Stribling D.S., Mazur P., Ge L., et al. Ghrelin neutralization by a ribonucleic acid-SPM ameliorates obesity in diet-induced obese mice. Endocrinology 2006, 147(3):1517-1526.
219. Sun Y., Wang P., Zheng H., Smith R.G. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA 2004, 101(13):4679-4684.
220. Gardiner J.V., Campbell D., Patterson M., Kent A., Ghatei M.A., Bloom S.R., et al. The hyperphagic effect of ghrelin is inhibited in mice by a diet high in fat. Gastroenterology 2010, 138(7):2468-2476. 76 e1.
221. Sugiishi A., Kimura M., Kamiya R., Ueki S., Yoneya M., Saito Y., et al. Derangement of ghrelin secretion after long-term high-fat diet feeding in rats. Hepatol Res 2013, [Epub ahead of print; doi: 10.1111/hepr.12062].
222. Li J., Wang S., Zhang N., Li Z., Li R., Li C. Effects of changing dietary fat content on plasma gut hormone concentrations in diet-induced obese and diet-resistant rats. Br J Nutr 2011, 105(6):879-886.
223. Kirchner H., Gutierrez J.A., Solenberg P.J., Pfluger P.T., Czyzyk T.A., Willency J.A., et al. GOAT links dietary lipids with the endocrine control of energy balance. Nat Med 2009, 15(7):741-745.
224. Kirchner H., Heppner K.M., Tschop M.H. The role of ghrelin in the control of energy balance. Handb Exp Pharmacol 2012, 209:161-184.
225. Weigle D.S., Cummings D.E., Newby P.D., Breen P.A., Frayo R.S., Matthys C.C., et al. Roles of leptin and ghrelin in the loss of body weight caused by a low fat, high carbohydrate diet. J Clin Endocrinol Metab 2003, 88(4):1577-1586.
226. Theander-Carrillo C., Wiedmer P., Cettour-Rose P., Nogueiras R., Perez-Tilve D., Pfluger P., et al. Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest 2006, 116(7):1983-1993.
227. Perez-Tilve D., Heppner K., Kirchner H., Lockie S.H., Woods S.C., Smiley D.L., et al. Ghrelin-induced adiposity is independent of orexigenic effects. FASEB J 2011, 25(8):2814-2822.
228. Tremaroli V., Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012, 489(7415):242-249.
229. Backhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004, 101(44):15718-15723.
230. Turnbaugh P.J., Backhed F., Fulton L., Gordon J.I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008, 3(4):213-223.
231. Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E., et al. A core gut microbiome in obese and lean twins. Nature 2009, 457(7228):480-484.
232. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444(7122):1022-1023.
233. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444(7122):1027-1031.
234. Furet J.P., Kong L.C., Tap J., Poitou C., Basdevant A., Bouillot J.L., et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 2010, 59(12):3049-3057.
235. Duncan S.H., Lobley G.E., Holtrop G., Ince J., Johnstone A.M., Louis P., et al. Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes (Lond) 2008, 32(11):1720-1724.
236. Zhang H., DiBaise J.K., Zuccolo A., Kudrna D., Braidotti M., Yu Y., et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 2009, 106(7):2365-2370.
237. Lam Y.Y., Ha C.W., Campbell C.R., Mitchell A.J., Dinudom A., Oscarsson J., et al. Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One 2012, 7(3):e34233.
238. de La Serre C.B., Ellis C.L., Lee J., Hartman A.L., Rutledge J.C., Raybould H.E. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol 2010, 299(2):G440-G448.
239. Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, Keilbaugh SA, Hamady M, Chen YY, et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology. 2009;137(5):1716-24 e1-2.
240. Kim K.A., Gu W., Lee I.A., Joh E.H., Kim D.H. High Fat diet-induced Gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One 2012, 7(10):e47713.
241. Murphy E.F., Cotter P.D., Healy S., Marques T.M., O'Sullivan O., Fouhy F., et al. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 2010, 59(12):1635-1642.
242. Ravussin Y., Koren O., Spor A., LeDuc C., Gutman R., Stombaugh J., et al. Responses of gut microbiota to diet composition and weight loss in lean and obese mice. Obesity (Silver Spring) 2012, 20(4):738-747.
243. Turnbaugh P.J., Ridaura V.K., Faith J.J., Rey F.E., Knight R., Gordon J.I. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 2009, 1(6):6ra14.
244. Parks B.W., Nam E., Org E., Kostem E., Norheim F., Hui S.T., et al. Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice. Cell Metab 2013, 17(1):141-152.
245. Duca F.A., Swartz T.D., Sakar Y., Covasa M. Increased oral detection, but decreased intestinal signaling for fats in mice lacking gut microbiota. PLoS One 2012, 7(6):e39748.
246. Swartz T.D., Duca F.A., de Wouters T., Sakar Y., Covasa M. Up-regulation of intestinal type 1 taste receptor 3 and sodium glucose luminal transporter-1 expression and increased sucrose intake in mice lacking gut microbiota. Br J Nutr 2011, 1-10.
247. Fredborg M., Theil P.K., Jensen B.B., Purup S. G protein-coupled receptor120 (GPR120) transcription in intestinal epithelial cells is significantly affected by bacteria belonging to the Bacteroides, Proteobacteria, and Firmicutes phyla. J Anim Sci 2012, 90(Suppl 4):10-12.
248. Cani P.D., Delzenne N.M. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr Opin Pharmacol 2009, 9(6):737-743.
249. Lam Y.Y., Mitchell A.J., Holmes A.J., Denyer G.S., Gummesson A., Caterson I.D., et al. Role of the gut in visceral fat inflammation and metabolic disorders. Obesity (Silver Spring) 2011, 19(11):2113-2120.
250. Ding S., Chi M.M., Scull B.P., Rigby R., Schwerbrock N.M., Magness S., et al. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One 2010, 5(8):e12191.
251. Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57(6):1470-1481.
252. Cani P.D., Neyrinck A.M., Fava F., Knauf C., Burcelin R.G., Tuohy K.M., et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007, 50(11):2374-2383.
253. Muccioli G.G., Naslain D., Backhed F., Reigstad C.S., Lambert D.M., Delzenne N.M., et al. The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol 2010, 6:392.
254. Bartholome A.L., Albin D.M., Baker D.H., Holst J.J., Tappenden K.A. Supplementation of total parenteral nutrition with butyrate acutely increases structural aspects of intestinal adaptation after an 80% jejunoileal resection in neonatal piglets. JPEN J Parenter Enteral Nutr 2004, 28(4):210-222. discussion 22-3.
255. Kleessen B., Hartmann L., Blaut M. Fructans in the diet cause alterations of intestinal mucosal architecture, released mucins and mucosa-associated bifidobacteria in gnotobiotic rats. Br J Nutr 2003, 89(5):597-606.
256. Tappenden K.A., Drozdowski L.A., Thomson A.B., McBurney M.I. Short-chain fatty acid-supplemented total parenteral nutrition alters intestinal structure, glucose transporter 2 (GLUT2) mRNA and protein, and proglucagon mRNA abundance in normal rats. Am J Clin Nutr 1998, 68(1):118-125.
257. Delzenne N.M., Cani P.D., Daubioul C., Neyrinck A.M. Impact of inulin and oligofructose on gastrointestinal peptides. Br J Nutr 2005, 93(Suppl 1):S157-S161.
258. Cani P.D., Lecourt E., Dewulf E.M., Sohet F.M., Pachikian B.D., Naslain D., et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 2009, 90(5):1236-1243.
259. Cani P.D., Joly E., Horsmans Y., Delzenne N.M. Oligofructose promotes satiety in healthy human: a pilot study. Eur J Clin Nutr 2006, 60(5):567-572.
260. Cani P.D., Neyrinck A.M., Maton N., Delzenne N.M. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1. Obes Res 2005, 13(6):1000-1007.
261. Levin B.E. Developmental gene x environment interactions affecting systems regulating energy homeostasis and obesity. Front Neuroendocrinol 2010, 31(3):270-283.
262. Moreno J.L., Willett K.C., Desilets A.R. Exenatide as a novel weight loss modality in patients without diabetes. Ann Pharmacother 2012, 46(12):1700-1706.
263. Trevaskis J.L., Turek V.F., Griffin P.S., Wittmer C., Parkes D.G., Roth J.D. Multi-hormonal weight loss combinations in diet-induced obese rats: therapeutic potential of cholecystokinin?. Physiol Behav 2010, 100(2):187-195.
264. Irwin N., Frizelle P., Montgomery I.A., Moffett R.C., O'Harte F.P., Flatt P.R. Beneficial effects of the novel cholecystokinin agonist (pGlu-Gln)-CCK-8 in mouse models of obesity/diabetes. Diabetologia 2012, 55(10):2747-2758.
265. Kootte R.S., Vrieze A., Holleman F., Dallinga-Thie G.M., Zoetendal E.G., de Vos W.M., et al. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes Obes Metab 2011, 14(2):112-120.
266. Dewulf E.M., Cani P.D., Claus S.P., Fuentes S., Puylaert P.G., Neyrinck A.M., et al. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 2012, 62(8):1112-1121.
267. Luo J., Van Yperselle M., Rizkalla S.W., Rossi F., Bornet F.R., Slama G. Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics. J Nutr 2000, 130(6):1572-1577.
268. Parnell J.A., Reimer R.A. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 2009, 89(6):1751-1759.
269. Peters H.P., Boers H.M., Haddeman E., Melnikov S.M., Qvyjt F. No effect of added beta-glucan or of fructooligosaccharide on appetite or energy intake. Am J Clin Nutr 2009, 89(1):58-63.
270. Vrieze A., Van Nood E., Holleman F., Salojarvi J., Kootte R.S., Bartelsman J.F., et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012, 143(4):913-6.e7.